{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T02:44:06Z","timestamp":1794624246943,"version":"4.9.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.jsbmb.2016.02.014","type":"journal-article","created":{"date-parts":[[2016,2,16]],"date-time":"2016-02-16T10:04:00Z","timestamp":1455617040000},"page":"145-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"PA","title":["Apparent mineralocorticoid excess and the long term treatment of genetic hypertension"],"prefix":"10.1016","volume":"165","author":[{"given":"Maryam","family":"Razzaghy-Azar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mabel","family":"Yau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Khattab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria I.","family":"New","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1-2","key":"10.1016\/j.jsbmb.2016.02.014_bib0005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1515\/jpem-2013-0235","article-title":"Remission of hypertension and electrolyte abnormalities following renal transplantation in a patient with apparent mineralocorticoid excess well documented throughout childhood","volume":"27","author":"Khattab","year":"2014","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.jsbmb.2016.02.014_bib0010","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0039-128X(84)80001-X","article-title":"11 beta-Hydroxysteroid dehydrogenase: fact or fancy?","volume":"44","author":"Monder","year":"1984","journal-title":"Steroids"},{"issue":"8618","key":"10.1016\/j.jsbmb.2016.02.014_bib0015","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0140-6736(88)90742-8","article-title":"Localisation of 11 beta-hydroxysteroid dehydrogenase\u2013tissue specific protector of the mineralocorticoid receptor","volume":"2","author":"Edwards","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.jsbmb.2016.02.014_bib0020","series-title":"Genetic Steroid Disorders","first-page":"392","article-title":"Apparent mineralocorticoid excess","author":"Yau","year":"2014"},{"issue":"1","key":"10.1016\/j.jsbmb.2016.02.014_bib0025","first-page":"1","article-title":"The prismatic case of apparent mineralocorticoid excess","volume":"79","author":"New","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4-5","key":"10.1016\/j.jsbmb.2016.02.014_bib0030","first-page":"751","article-title":"Apparent mineralocorticoid excess causing hypertension and hypokalemia in children","volume":"8","author":"New","year":"1986","journal-title":"Clin. Exp. Hypertens. A"},{"issue":"3","key":"10.1016\/j.jsbmb.2016.02.014_bib0035","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1043-2760(00)00356-8","article-title":"Apparent mineralocorticoid excess","volume":"12","author":"Wilson","year":"2001","journal-title":"Trends Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.jsbmb.2016.02.014_bib0040","doi-asserted-by":"crossref","first-page":"5264","DOI":"10.1210\/endo.137.12.8940344","article-title":"Exclusion of corticosterone from epithelial mineralocorticoid receptors is insufficient for selectivity of aldosterone action: in vivo binding studies","volume":"137","author":"Funder","year":"1996","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.jsbmb.2016.02.014_bib0045","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1203\/00006450-197404000-00006","article-title":"Treatment of precocious puberty with cyproterone acetate","volume":"8","author":"Werder","year":"1974","journal-title":"Pediatr. Res."},{"issue":"5","key":"10.1016\/j.jsbmb.2016.02.014_bib0050","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1210\/jcem-44-5-924","article-title":"Evidence for an unidentified steroid in a child with apparent mineralocorticoid hypertension","volume":"44","author":"New","year":"1977","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.jsbmb.2016.02.014_bib0055","first-page":"2244","article-title":"Examination of genotype and phenotype relationships in 14 patients with apparent mineralocorticoid excess","volume":"83","author":"Dave-Sharma","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.jsbmb.2016.02.014_bib0060","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1172\/JCI113592","article-title":"Syndrome of apparent mineralocorticoid excess: a defect in the cortisol-cortisone shuttle","volume":"82","author":"Stewart","year":"1988","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.jsbmb.2016.02.014_bib0065","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2265.1983.tb00038.x","article-title":"Affinity of liquorice derivatives for mineralocorticoid and glucocorticoid receptors","volume":"19","author":"Armanini","year":"1983","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"3","key":"10.1016\/j.jsbmb.2016.02.014_bib0070","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.tem.2005.02.011","article-title":"Monogenic low renin hypertension","volume":"16","author":"New","year":"2005","journal-title":"Trends Endocrinol. Metab."},{"issue":"8994","key":"10.1016\/j.jsbmb.2016.02.014_bib0075","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0140-6736(96)90211-1","article-title":"Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11 beta-hydroxysteroid dehydrogenase type 2 gene","volume":"347","author":"Stewart","year":"1996","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jsbmb.2016.02.014_bib0080","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/ng0895-394","article-title":"Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase","volume":"10","author":"Mune","year":"1995","journal-title":"Nat. Genet."},{"issue":"1-2","key":"10.1016\/j.jsbmb.2016.02.014_bib0085","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.mce.2003.10.019","article-title":"Molecular basis for the apparent mineralocorticoid excess syndrome in the Oman population","volume":"217","author":"Quinkler","year":"2004","journal-title":"Mol. Cell. Endocrinol."},{"issue":"4","key":"10.1016\/j.jsbmb.2016.02.014_bib0090","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0039-128X(96)00012-8","article-title":"Apparent mineralocorticoid excess: type I and type II","volume":"61","author":"Mantero","year":"1996","journal-title":"Steroids"},{"issue":"4","key":"10.1016\/j.jsbmb.2016.02.014_bib0095","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1681\/ASN.2006111235","article-title":"Impaired protein stability of 11beta-hydroxysteroid dehydrogenase type 2: a novel mechanism of apparent mineralocorticoid excess","volume":"18","author":"Atanasov","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6 Pt 2","key":"10.1016\/j.jsbmb.2016.02.014_bib0100","first-page":"I94","article-title":"Radioreceptor assay of plasma mineralocorticoid activity. Role of aldosterone, cortisol, and deoxycorticosterone in various mineralocorticoid-excess states","volume":"46","author":"Lan","year":"1980","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.jsbmb.2016.02.014_bib0105","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1210\/jcem-55-3-516","article-title":"A radioreceptor assay for direct measurement of plasma free glucocorticoid activity","volume":"55","author":"Lan","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.jsbmb.2016.02.014_bib0110","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/BF03343755","article-title":"Does kidney transplantation normalise cortisol metabolism in apparent mineralocorticoid excess syndrome?","volume":"23","author":"Palermo","year":"2000","journal-title":"J. Endocrinol. Invest."},{"issue":"7","key":"10.1016\/j.jsbmb.2016.02.014_bib0115","first-page":"2263","article-title":"A mutation in the HSD11B2 gene in a family with apparent mineralocorticoid excess","volume":"80","author":"Wilson","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.jsbmb.2016.02.014_bib0120","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1210\/jc.2007-2430","article-title":"Clinical review: antiandrogens for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials","volume":"93","author":"Swiglo","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.jsbmb.2016.02.014_bib0125","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1210\/en.2010-0925","article-title":"11beta-hydroxysteroid dehydrogenase type 2 deficiency accelerates atherogenesis and causes proinflammatory changes in the endothelium in apoe-\/- mice","volume":"152","author":"Deuchar","year":"2011","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.jsbmb.2016.02.014_bib0130","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1161\/HYPERTENSIONAHA.107.103267","article-title":"Selective mineralocorticoid receptor blocker eplerenone reduces resistance artery stiffness in hypertensive patients","volume":"51","author":"Savoia","year":"2008","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/j.jsbmb.2016.02.014_bib0135","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure: Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.jsbmb.2016.02.014_bib0140","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/HYPERTENSIONAHA.111.169961","article-title":"Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): a randomized, double-blind, placebo-controlled trial","volume":"57","author":"Vaclavik","year":"2011","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.jsbmb.2016.02.014_bib0145","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1086\/301955","article-title":"Molecular basis for hypertension in the type II variant of apparent mineralocorticoid excess","volume":"63","author":"Li","year":"1998","journal-title":"Am. J. Hum. Genet."},{"issue":"8","key":"10.1016\/j.jsbmb.2016.02.014_bib0150","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.amjhyper.2005.02.020","article-title":"Analysis of the 11beta-hydroxysteroid dehydrogenase type 2 gene (HSD11B2) in human essential hypertension","volume":"18","author":"Mariniello","year":"2005","journal-title":"Am. J. Hypertens."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076016300280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076016300280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:52:20Z","timestamp":1760745140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076016300280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":30,"alternative-id":["S0960076016300280"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2016.02.014","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apparent mineralocorticoid excess and the long term treatment of genetic hypertension","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2016.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}